News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
12don MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
SINGAPORE: All Singapore Haj pilgrims travelling to Saudi Arabia in June are required to be vaccinated for influenza and ...
Colleges that require students to undergo a COVID-19 vaccine will have their federal funding ended if House lawmakers get ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
The vaccine causes your body to make a small amount of COVID protein, which your body recognizes as foreign and destroys.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback